The efficacy of onabotulinumtoxinA in patients with previous failed augmentation cystoplasty: Cohort series and literature review.

Bogdan ToiaMahreen H PakzadRizwan HamidDan N WoodTamsin J Greenwell Jeremy L Ockrim

Published in: Neurourology and urodynamics (2020)

Forty-three percent of patients responded well to intra-detrusor onabotulinumtoxinA injections. This avoided the need for more invasive surgery and had a positive impact on their quality of life.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
minimally invasive
peritoneal dialysis
prognostic factors
coronary artery bypass
patient reported outcomes
atrial fibrillation
botulinum toxin